ACOG's Delegation to the AMA: Historic Advances for Reproductive Health
Physicians from across the nation convene twice a year for the American Medical Association (AMA) House of Delegates (HOD) to determine AMA policy on issues impacting health care access, delivery,...
Discussion: At the June meeting, ACOG's hard-working AMA delegation achieved major gains, including securing AMA support for important reproductive health resolutions that will empower AMA to vigorously pursue protective efforts, defend against new threats and restrictions, and partner with specialties, such as ACOG.
Society of family planning clinical recommendations: Contraception and abortion care for persons who use substances - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35644230/
Substance use and substance use disorder remain significant public health crises. Substance use disorder, or addiction, is a stigmatized and misunderstood disease. Accessing contraception and abortion care is particularly challenging,...
Discussion: There is consensus among informants from the 5 sectors for expanding reproductive health services in primary care. This will require reproductive health-related training for providers, organizational buy-in, and system protocol changes, including unbiased contraceptive counseling of all methods, specifically balancing discussion of...
Conclusion: This study demonstrated that women with chronic disease take up contraception at similar rates to their same aged peers in the community, however women diagnosed with AICs were more likely to engage in low efficacy methods or no contraception.
Fertility Preferences and Contraceptive Change in Low- and Middle-Income Countries - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35727081/
The past four decades have witnessed an enormous increase in modern contraception in most low- and middle-income countries. We examine the extent to which this change can be attributed to...
Conclusion: We have provided further empirical verification of the premise that has justified the investment in family planning services in many countries during the past five decades, namely that unsatisfied demand for fertility regulation is widespread (Alkema et al. 2013; Cahill et al. 2018; Kantorová et al. 2020) and that satisfying this...
Discussion: Studies should assess bleeding characteristics for a minimum of 12 months for 21/7, 24/4, extended cycle or continuous regimens, two years for injectables, and the full duration of use for long-acting contraceptives. Describing pattern, flow and duration as independent categories allows a fuller understanding of the bleeding outcomes...